Pharmaceutical Products for CDER Research Studies - IDIQ
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | May 11, 2026 |
| Due Date: | May 15, 2026 |
| Solicitation No: | 75F40126Q132721 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
- Updated Published Date: May 11, 2026 09:49 am CDT
- Original Published Date: May 01, 2026 09:37 am CDT
- Updated Date Offers Due: May 15, 2026 01:00 pm CDT
- Original Date Offers Due: May 15, 2026 01:00 pm CDT
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: May 30, 2026
- Original Inactive Date: May 30, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
-
NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
-
Place of Performance:
USA
5/11/2026:
Questions and answers:
- Current or most recent incumbent contractor/vendor name
Response: WE Pharma, LLC
- Previous contract number and/or SAM.gov solicitation number
Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072.
- Contract award value or estimated annual spend
Response: The prior IDIQ Ceiling was $9,500,000.00.
- Historical pricing information or awarded pricing structure
Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A. Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for releasability.
- Period of performance of the incumbent contract
Response: 9/30/2020 to 9/29/2025.
- Any publicly available award documentation or reference links
Response: None that we are aware of.
5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan.
See attached combined synopsis/solicitation.
- 11601 Landsdown St Floor 13
- Rockville , MD 20852
- USA
- Nick Sartain
- nick.sartain@fda.hhs.gov
- Phone Number 3017961988
- May 11, 2026 09:49 am CDTCombined Synopsis/Solicitation (Updated)
- May 04, 2026 03:13 pm CDT Combined Synopsis/Solicitation (Updated)
- May 01, 2026 09:37 am CDT Combined Synopsis/Solicitation (Original)
- Apr 02, 2026 10:55 pm CDT Sources Sought (Original)
Related Document
| May 1, 2026 | [Combined Synopsis/Solicitation (Original)] Pharmaceutical Products for CDER Research Studies - IDIQ |
| May 4, 2026 | [Combined Synopsis/Solicitation (Updated)] Pharmaceutical Products for CDER Research Studies - IDIQ |
See Also
Follow DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program Active Contract Opportunity
DEPT OF DEFENSE
Due by 12/01/2026
Follow DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program Active Contract Opportunity
DEPT OF DEFENSE
Due by 12/01/2026
Follow DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program Active Contract Opportunity
DEPT OF DEFENSE
Due by 12/01/2026
Follow 6550--Lab - ABBOTT ARCHITECT REAGENTS AND CONSUMABLES Active Contract Opportunity Notice ID
VETERANS AFFAIRS, DEPARTMENT OF
Due by 11/12/2026